NEWS
NEWS
The top 10 drug launches of 2019
Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from 2019's class of top drug launches. Instead,...
Silicon Valley’s most anticipated slide deck just dropped. What does it mean for biopharma’s digital teams?
These aren’t the typical slides you’d see at Endpoints — no molecules, clinical programs, or p-values. Instead, we’ll talk digital and internet...
The top 10 most-expensive meds in the U.S.—and they’re not the usual suspects
Two new gene therapies—from Novartis and Spark Therapeutics—carry price tags higher than any other drugs in the U.S., elbowing aside the brands...
If pharma looks slow to adopt AI, it’s got good reason, expert says
Pharma hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. But while it’s drawn...
Big Pharma Cuts, Current and Coming
Word came out just before the weekend (first at Endpoints) that GlaxoSmithKline is laying off R&D employees at both Stevenage (UK) and...
How biopharma companies use NIH and vice versa
You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals...
In another CRISPR first, Penn researchers dose US cancer patients with gene-edited T cell therapy
CRISPR has been tested in US patients for the first time — but perhaps not in the manner you imagined. The University of Pennsylvania has led the...
‘Patients are not a company’s resource’: FDA cancer czar Richard Pazdur has a bone to pick with the top R&D execs in cancer
If there’s one law in oncology R&D, it’s that you don’t cross FDA cancer czar Richard Pazdur. Pazdur is famous for cutting companies to...
2020: What does the future hold for the manufacturing and clinical landscape?
Pharma IQ spoke to Jeremy Schafer and Scott Marshall to find out their predictions. The manufacturing and clinical landscapes are set to see...
A key step for the future of personalized medicine: CRISPR immunity and Mathematical Cryptanalysis.
In this analysis, Michael A. Popov, Director Researcher at Prime States Quantum Lab looks at the future trends and applications of the CRISPR...
Pharma’s summer of punk: Who’s playing the hits — or taking a hit — on the world innovation tour
You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals...
Giant study shows Apple Watch can spot heart rhythm changes — but it’s far from ‘medical-grade technology’
New Orleans — New results of a gigantic study testing how well the Apple Watch detects important heart-rhythm changes offer a tantalizing glimpse...
Recent Posts
More Than Half of Doctors Now Part of Healthcare Systems
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days